Molecular Targets of Fatty Acid Ethanolamides in Asthma
ReviewHumansOther animals
- Design
- Review
- Subjects
- Not stated in the abstract
- Dose used in the study
- Not stated in the abstract
- Duration
- Not stated in the abstract
- What was measured
- What role fatty acid ethanolamides, particularly palmitoylethanolamide, play in asthma: a review of neuro-immune interactions and nerve growth factor
What the authors reported
Nerve growth factor, which regulates mast cell differentiation and is linked to allergic airway inflammation, is one target of palmitoylethanolamide in asthma, the authors propose. They describe PEA's action on the nervous system and on mast cell activation and degranulation. No trial data are given.
Limits of this study
A narrative review with no asthma trial data in the abstract. The authors declare no conflict of interest.
Source
PubMed 30939862 · doi:10.3390/medicina55040087
Entry checked against the abstract on PubMed on 2026-09-22. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.